Effect of tea polyphenol on cytokine gene expression in rats with alcoholic liver disease

Hepatobiliary and Pancreatic Diseases International

Volumn 5, Issue 2, 2006, Pages 268-272

  Zhang, Xing Guo ^a   Xu, Ping ^a   Liu, Qiong ^a   Yu, Chao Hui ^a   Zhang, Yu ^a   Chen, Shao Hua ^a   Li, You Ming ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Alcoholic liver disease; Cytokine; Gene expression; Tea polyphenol

Indexed keywords

ALCOHOL; CD27 ANTIGEN; COLLAGEN; COLONY STIMULATING FACTOR 1; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 3; INTERLEUKIN 3 RECEPTOR; INTERLEUKIN 4; INTERLEUKIN 5 RECEPTOR; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 7 RECEPTOR; POLYPHENOL DERIVATIVE; SODIUM CHLORIDE;

ALCOHOL LIVER DISEASE; ALCOHOLIC FATTY LIVER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CELL SWELLING; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; GENE EXPRESSION REGULATION; HISTOPATHOLOGY; LIVER CELL; LIVER NECROSIS; LIVER PROTECTION; NONHUMAN; PATHOGENESIS; RAT; STATISTICAL ANALYSIS; TEA; UPREGULATION;

ANIMALS; BIOPSY, NEEDLE; CYTOKINES; DISEASE MODELS, ANIMAL; FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION; IMMUNOHISTOCHEMISTRY; LIVER; LIVER DISEASES, ALCOHOLIC; MALE; PHENOLS; PROBABILITY; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; REFERENCE VALUES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUES;

EID: 33744784825     PISSN: 14993872     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. McClain C, Barve S, Joshi-Barve S, Song Z, Deaciuc I, Chen T, et al. Dysregulated cytokine metabolism, altered hepatic methionine metabolism and proteasome dysfunction in alcoholic liver disease. Alcohol Clin Exp Res 2005;29 (11 Suppl):180S-188S.
2. Kono H, Rusyn I, Yin M, Gabele E, Yamashina S, Dikalova A, et al. NADPH oxidase-derived free radicals are key oxidants in alcohol-induced liver disease. J Clin Invest 2000;106: 867-872.
3. Higdon JV, Frei B. Tea catechins and polyphenols: health effects, metabolism, and antioxidant functions. Crit Rev Food Sci Nutr 2003;43:89-143.
4. Frei B, Higdon JV. Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 2003;133:3275S-3284S.
5. Zhu XM, Zhao ZD, Huang ZL. Experimental study on tea polyphenols in prevention of hyperlipidemia. Zhongguo Zhong Xi Yi Jie He Za Zhi 1996;16:549-551.
6. Chevallier M, Guerret S, Chossegros P, Gerard F, Grimaud JA. A histological semiquantitative scoring system for evaluation of hepatic fibrosis in needle liver biopsy specimens: comparison with morphometric studies. Hepatology 1994;20:349-355.
7. Zhang FK, Zhang JY, Jia JD. Treatment of patients with alcoholic liver disease. Hepatobiliary Pancreat Dis Int 2005;4:12-17.
8. Varilek GW, Yang F, Lee EY, de Villiers WJ, Zhong J, Oz HS, et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr 2001;131:2034-2039.
9. Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr 1998;128: 2334-2340.
10. Chen QK, Chen HY, Huang KH, Zhong YQ, Han JA, Zhu ZH, et al. Clinical features and risk factors of patients with fatty liver in Guangzhou area. World J Gastroenterol 2004;10:899-902.
11. Wang GX, Wang BY, Liu CR. The relationship between activities of hepatic and gastric alcohol dehydrogenase and occurrence of chronic alcoholic liver disease. Hepatobiliary Pancreat Dis Int 2002;1:406-410.
12. Koch OR, Pani G, Borrello S, Colavitti R, Cravero A, Farre S, et al. Oxidative stress and antioxidant defenses in ethanol-induced cell injury. Mol Aspects Med 2004;25:191-198.
13. Leevy CB, Elbeshbeshy HA. Immunology of alcoholic liver disease. Clin Liver Dis 2005;9:55-66.
14. Takeyama Y, Kamimura S, Kuroiwa A, Sohda T, Irie M, Shijo H, et al. Role of Kupffer cell-derived reactive oxygen intermediates in alcoholic liver disease in rats in vivo. Alcohol Clin Exp Res 1996;20(9 Suppl):335A-339A.
15. Kamimura S, Tsukamoto H. Cytokine gene expression by Kupffer cells in experimental alcoholic liver disease. Hepatology 1995;22(4 Pt 1):1304-1309.
16. Hoek JB, Pastorino JG. Ethanol, oxidative stress, and cytokine-induced liver cell injury. Alcohol 2002;27:63-68.
17. McClain CJ, Hill DB, Song Z, Deaciuc I, Barve S. Monocyte activation in alcoholic liver disease. Alcohol 2002;27:53-61.
18. McClain CJ, Song Z, Barve SS, Hill DB, Deaciuc I. Recent advances in alcoholic liver disease. IV. Dysregulated cytokine metabolism in alcoholic liver disease. Am J Physiol Gastrointest Liver Physiol 2004;287:6497-502.
19. Gallucci RM, Sloan DK, O'Dell SJ, Reinke LA. Differential expression of liver interleukin-6 receptor-alpha in female versus male ethanol-consuming rats. Alcohol Clin Exp Res 2004;28: 365-373.
20. Valles SL, Blanco AM, Azorin I, Guasch R, Pascual M, Gomez-Lechon MJ, et al. Chronic ethanol consumption enhances interleukin-1-mediated signal transduction in rat liver and in cultured hepatocytes. Alcohol Clin Exp Res 2003;27:1979-1986.
21. Chen WX, Xu GY, Yu CH, Wang P, Yu M, Xu P, et al. Correlation of polymorphism in the interleukin-1 receptor antagonist gene intron 2 with alcoholic liver disease. Hepatobiliary Pancreat Dis Int 2005;4:41-45.